Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
35.21
-0.09 (-0.25%)
Dec 15, 2025, 11:46 AM EST - Market open
Azenta Revenue
In the fiscal year ending September 30, 2025, Azenta had annual revenue of $593.82M with 3.55% growth. Azenta had revenue of $158.95M in the quarter ending September 30, 2025, with 5.21% growth.
Revenue (ttm)
$593.82M
Revenue Growth
+3.55%
P/S Ratio
2.72
Revenue / Employee
$197,940
Employees
3,000
Market Cap
1.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 593.82M | 20.37M | 3.55% |
| Sep 30, 2024 | 573.45M | 21.96M | 3.98% |
| Sep 30, 2023 | 551.49M | -4.01M | -0.72% |
| Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
| Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
| Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
| Sep 30, 2019 | 334.18M | -297.38M | -47.09% |
| Sep 30, 2018 | 631.56M | 104.06M | 19.73% |
| Sep 30, 2017 | 527.50M | 93.49M | 21.54% |
| Sep 30, 2016 | 434.01M | -118.70M | -21.48% |
| Sep 30, 2015 | 552.71M | 69.86M | 14.47% |
| Sep 30, 2014 | 482.85M | 60.41M | 14.30% |
| Sep 30, 2013 | 422.44M | -66.54M | -13.61% |
| Sep 30, 2012 | 488.98M | -199.12M | -28.94% |
| Sep 30, 2011 | 688.11M | 95.13M | 16.04% |
| Sep 30, 2010 | 592.97M | 374.27M | 171.13% |
| Sep 30, 2009 | 218.71M | -307.66M | -58.45% |
| Sep 30, 2008 | 526.37M | -216.89M | -29.18% |
| Sep 30, 2007 | 743.26M | 135.76M | 22.35% |
| Sep 30, 2006 | 607.49M | 237.72M | 64.29% |
| Sep 30, 2005 | 369.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
AZTA News
- 4 days ago - Azenta, Inc. (AZTA) Analyst/Investor Day Transcript - Seeking Alpha
- 4 days ago - Azenta Authorizes $250 Million Share Repurchase Program - PRNewsWire
- 7 days ago - Why a $5 Million Bet on Azenta Could Pay Off After a 70% Stock Slide - The Motley Fool
- 23 days ago - Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 - PRNewsWire
- 4 weeks ago - Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast - PRNewsWire
- 5 weeks ago - Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer - PRNewsWire
- 2 months ago - Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana - PRNewsWire